TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/21 07:30 | 11/18/21 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P | 50 | 35.09 | 0 | 1 | 0 | 427 | I | |||||||||||||||
5/13/21 07:05 | 5/12/21 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P | 29 | 58.15 | 0 | 1 | 0 | 425 | I | |||||||||||||||
6/30/20 08:20 | 6/29/20 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P | 51 | 78.50 | 0 | 1 | 0 | 409 | D | |||||||||||||||
6/27/19 07:18 | 6/25/19 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P.m | 374 | 23.10 | 0 | 16 | 2 | 674 | D | |||||||||||||||
5/15/19 07:21 | 5/13/19 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P | 100 | 21.44 | 0 | 5 | 1 | 658 | D | |||||||||||||||
3/21/19 07:05 | 3/19/19 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | P | 62 | 12.18 | 0 | 5 | 1 | 653 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |